These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3032607

  • 1. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
    Hodinka RL, Jack-Wait K, Wannamaker N, Walden TP, Gilligan PH.
    Eur J Clin Microbiol; 1987 Feb; 6(1):100-3. PubMed ID: 3032607
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.
    Jorgensen JH, Maher LA, Redding JS.
    Eur J Clin Microbiol; 1987 Feb; 6(1):91-6. PubMed ID: 3032612
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
    Verbist L.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):340-2. PubMed ID: 3032099
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Machka K, Braveny I.
    Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
    [Abstract] [Full Text] [Related]

  • 5. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
    Pohlod DJ, Saravolatz LD, Somerville MM.
    J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of LY146032 (daptomycin), a new peptolide.
    Ehlert F, Neu HC.
    Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611
    [Abstract] [Full Text] [Related]

  • 7. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F.
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [Abstract] [Full Text] [Related]

  • 8. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
    Benson CA, Beaudette F, Trenholm G.
    J Antimicrob Chemother; 1987 Aug; 20(2):191-6. PubMed ID: 2822645
    [Abstract] [Full Text] [Related]

  • 9. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children.
    Kline MW, Mason EO, Kaplan SL, Lamberth LB, Johnson GS.
    J Antimicrob Chemother; 1987 Aug; 20(2):203-7. PubMed ID: 2822647
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 11. In-vitro activity of LY146032 against Staphylococcus aureus, Listeria monocytogenes, Corynebacterium JK, and Bacillus spp., in comparison with various antibiotics.
    Van der Auwera P, Grenier P, Klastersky J.
    J Antimicrob Chemother; 1987 Aug; 20(2):209-12. PubMed ID: 2822648
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D, Mildvan D, Handwerger S.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
    Biavasco F, Lupidi R, Varaldo PE.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):331-8. PubMed ID: 1534977
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 Feb; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

  • 15. [Bactericidal effect of daptomycin (LY 146032) compared with vancomycine and teicoplanin against gram-positive bacteria].
    Caillon J, Juvin ME, Pirault JL, Drugeon HB.
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):540-8. PubMed ID: 2552378
    [Abstract] [Full Text] [Related]

  • 16. Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.
    Gorzynski EA, Amsterdam D, Beam TR, Rotstein C.
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2019-22. PubMed ID: 2532875
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of LY146032 against gram-positive bacteria.
    Silva M, Jacobus NV, Gorbach SL.
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):79-85. PubMed ID: 2838217
    [Abstract] [Full Text] [Related]

  • 18. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R, SENTRY Surveillance Program, Spain (2002-2006).
    Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861
    [Abstract] [Full Text] [Related]

  • 19. Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
    Knapp CC, Washington JA.
    Antimicrob Agents Chemother; 1986 Dec; 30(6):938-9. PubMed ID: 3028254
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.
    Chow AW, Cheng N.
    Antimicrob Agents Chemother; 1988 May; 32(5):788-90. PubMed ID: 2840019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.